Mastodon

Limontar® (Tablets) Instructions for Use

Marketing Authorization Holder

Biotiki MNPK, LLC (Russia)

ATC Code

A13A (General tonic preparations)

Active Substances

Succinic acid (BHP British Herbal Pharmacopoeia)

Citric acid (Ph.Eur. European Pharmacopoeia)

Dosage Form

Bottle OTC Icon Limontar® Soluble tablets 50 mg+200 mg: 30 pcs.

Dosage Form, Packaging, and Composition

Soluble tablets white tablets with marbling elements, biconvex in shape.

1 tab.
Citric acid monohydrate 50 mg
Succinic acid 200 mg

Excipients: magnesium stearate – 3 mg.

30 pcs. – blister packs (1) – cardboard packs.

Clinical-Pharmacological Group

A drug that improves tissue metabolism and energy supply, reducing tissue hypoxia

Pharmacotherapeutic Group

Metabolic agent

Pharmacological Action

A combined medicinal product, a regulator of tissue metabolism, possesses antihypoxic and antioxidant properties, increases appetite, and reduces the toxic effect of ethanol.

By stimulating redox reactions, respiration processes, and ATP synthesis, it activates the physiological functions of organs and tissues (stimulates the body’s adaptive and compensatory-protective capabilities); increases mental and physical performance; improves the course of pregnancy, fetal growth and development; increases the secretion of gastric juice, the formation of hydrochloric acid and appetite; reduces the toxic effect of alcohol.

The effect appears 10-20 minutes after oral administration.

Pharmacokinetics

Succinic and citric acids are completely metabolized to water and carbon dioxide and do not accumulate.

Indications

Increasing the nonspecific reactivity of the body during pregnancy; prevention of complications in fetal hypoxia and hypotrophy, miscarriage; alcohol intoxication (mild and moderate severity); treatment of binge states in patients with chronic alcoholism (as part of complex therapy); alcohol withdrawal syndrome; asthenovegetative syndrome (asthenia, decreased performance, decreased appetite); as a “test breakfast” for the study of the secretory and acid-forming function of the stomach.

ICD codes

ICD-10 code Indication
F10.2 Chronic alcoholism
F10.3 Withdrawal state
F48.0 Neurasthenia
O26.2 Medical care for women with recurrent pregnancy loss
P05 Slow fetal growth and fetal malnutrition
P20 Intrauterine hypoxia
R63.0 Anorexia
T51 Toxic effect of alcohol
Z51.4 Preparatory procedures for subsequent treatment or examination, not elsewhere classified
Z73.0 Burn-out
ICD-11 code Indication
6A8Z Affective disorders, unspecified
6C40.2Z Alcohol dependence, unspecified
6C40.4Z Alcohol withdrawal syndrome, unspecified
6C40.Z Disorders due to alcohol use, unspecified
8D44.Y Other specified alcohol-related neurological disorders
JA65.4 Medical care for pregnant woman with history of habitual abortion
KA20.Z Disorders of newborn related to slow fetal growth or fetal malnutrition, unspecified
KB20.Z Intrauterine hypoxia, unspecified
MG43.7 Anorexia
NE61 Toxic effect of poisonous substances, chiefly nonmedicinal, not elsewhere classified
QB9A Preparatory procedures for subsequent treatment
QD85 Burn-out

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

The drug is taken orally, before meals. Before administration, the tablet is crushed and dissolved in water with baking soda or mineral water.

For pregnant women, 1 tab./day is prescribed for 10 days in the first trimester (at 12-14 weeks of pregnancy) and in the second trimester (24-26 weeks of pregnancy). In the third trimester, it is prescribed 10-25 days before delivery. The total dose of the drug during pregnancy is 5-7.5 g.

For the prevention of alcohol intoxication – 1 tab. of the drug 20-60 minutes before alcohol consumption. For acute alcohol intoxication, the drug is prescribed 1 tab. 2-4 times/day at intervals of 1-2.5 hours. For relieving binge states in chronic alcoholism, 1 tab. is prescribed 3-4 times/day for 4-10 days, either independently or in combination with traditional medications.

As a means for a “test breakfast”, take orally, on an empty stomach, 1 tab. previously dissolved in 10-15 ml of water.

Adverse Reactions

Possible gastralgia, hypersecretion of gastric juice (usually these phenomena resolve on their own within 3-5 minutes).

In persons prone to arterial hypertension, with systematic use – increased blood pressure.

Contraindications

Arterial hypertension; ischemic heart disease; angina pectoris; gastric and duodenal ulcer (in the acute phase); glaucoma; late gestosis (severe form); hypersensitivity to the components of the drug.

Use in Pregnancy and Lactation

The drug is prescribed to pregnant women according to indications.

Special Precautions

If a feeling of heaviness in the epigastric region appears, it is prescribed after meals.

Drug Interactions

Weakens the effect of hypnotic drugs and tranquilizers.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS